BDH Peer Comparison

NSE: MBIND | BSE: 524828

₹500.00

₹-2.95 (-0.59%)

As on 21-Sep-2026 12:58IST

Market cap

₹284 Cr

Revenue (TTM)

₹100 Cr

P/E Ratio

24.2

P/B Ratio

3.6

Div. Yield

1 %

Edit

	BDH	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Market cap (₹ Cr)	284	21,092	20,394	17,990	18,432
Revenue (₹ Cr)	100	2,287	1,682	3,230	2,570
Net Profit (₹ Cr)	11.71	678.07	273.51	666.92	735.15
Net Margin (%)	11.50	28.10	16.19	20.60	26.88
RoE (%)	15.86	19.73	11.15	18.75	19.16
Price to Earnings	24.24	31.70	68.59	27.94	25.07
Price-To-Book	3.62	5.74	7.59	4.46	4.18

Income Statement (₹ Cr)

	BDH	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Operating Revenue	99.71	2,287.33	1,682.47	3,229.67	2,569.77
Total Income	101.85	2,413.29	1,689.83	3,237.12	2,735.39
Total Expenditure	84.48	1,490.75	1,203.91	2,090.06	1,628.14
EBITDA	15.23	796.58	478.55	1,139.61	941.63
Depreciation	0.86	78.10	126.01	281.06	57.58
EBIT	14.37	718.48	352.55	858.55	884.05
Interest	0.07	0.88	52.11	190.64	7.69
Other Income	2.14	125.96	7.37	7.45	165.62
Exceptional Items	0.00	0.00	12.16	-17.24	-49.16
Profit before Tax	16.45	843.56	319.96	658.12	992.82
Provision for Tax	4.74	165.49	46.45	-8.80	257.67
Profit after Tax	11.71	678.07	273.51	666.92	735.15

	BDH	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Shareholder's Funds	77.01	3,586.42	2,591.20	3,902.67	4,202.90
Minority Interest	0.00	-12.71	0.00	-21.81	0.00
Non-Current Liabilities	2.10	28.74	266.35	1,392.75	91.50
Current Liabilities	19.97	385.94	848.06	2,077.10	627.48
Total Liabilities	99.09	4,037.51	3,705.61	7,246.72	4,921.88

	BDH	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Non-Current Assets	19.17	1,291.22	2,525.44	5,617.77	770.28
Current Assets	79.80	2,585.66	1,109.77	1,539.85	3,803.22
Total Assets	99.09	4,037.51	3,705.61	7,246.72	4,921.88
Total Debt*	2.02	0.57	657.97	2,309.68	2.50
Net Current Assets	59.82	2,199.72	261.71	-537.25	3,175.74
Contingent Liabilities	0.12	17.53	160.01	51.57	370.49

	BDH	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Cash From Operating Activities	-2.41	523.24	342.18	537.99	967.57
Cash Flow from Investing Activities	2.22	-582.30	-325.92	-369.46	-561.67
Cash from Financing Activities	-1.61	-46.46	13.62	-313.53	-798.31
Net Cash Inflow / Outflow	-1.81	-105.52	29.88	-145.00	-392.41

	BDH	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
ROCE (%)	20.88	24.97	11.43	14.47	23.39
ROE (%)	15.86	19.73	11.15	18.75	19.16
ROA (%)	12.59	18.69	7.80	9.26	14.95
EBIT Margin (%)	14.41	31.41	20.95	26.58	34.40
Net Margin (%)	11.50	28.10	16.19	20.60	26.88
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	BDH	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Revenue Growth (%)	44.77	15.01	27.91	9.59	10.69
EBIT Growth (%)	32.36	18.45	58.32	16.84	24.14
Net Profit Growth (%)	22.85	19.61	149.56	62.68	-9.09
EPS Growth (%)	22.85	17.73	-3.57	67.41	14.40
Book Value Growth (%)	12.24	26.75	9.67	36.71	-0.34

	BDH	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Price / Earnings	24.73	31.39	71.24	27.75	23.73
Price / Book Value	3.69	5.69	7.43	4.54	4.15
Dividend Yield (%)	0.99	0.29	0.06	0.00	1.87
EV/EBITDA	17.22	24.96	43.00	18.03	16.14
Market Cap (₹ Cr)	203.06	11,439.22	6,819.66	17,980.08	21,592.90

	BDH	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debt to Equity	0.00	0.00	0.07	0.24	0.00
Short term debt to equity ratio	0.03	0.00	0.16	0.12	0.00
Current Ratio	4.00	6.70	1.31	0.74	6.06
Quick Ratio	3.73	5.59	0.88	0.53	5.31
Interest Coverage	242.88	959.59	7.14	4.45	130.11

	BDH	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debtors to sales (%)	31.70	36.10	30.84	21.07	7.07
Asset Turnover	1.07	0.63	0.48	0.45	0.52
Receivable days	87.10	121.68	113.81	63.88	26.06
Inventory Days	24.27	63.83	84.76	43.27	65.95
Payable days	89.90	108.28	101.94	151.85	81.01
Cash Conversion Cycle	21.47	77.23	96.62	-44.70	11.00

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.